Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudy Juliano

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Cell Biology|May 1, 2009
SCAI blocks MAL-evolent effects on cancer cell invasionRudy Juliano
Nature Cell Biology|July 2, 2003
Movin' on through with Cdc2Rudy Juliano
Science (New York, N.Y.)|April 27, 2013
Strategy behind science policy decisionsRudy Juliano
The New England Journal of Medicine|March 3, 2007
Bugging tumors to put drugs on targetRudy Juliano
Nature Reviews. Drug Discovery|March 2, 2013
Nanomedicine: is the wave cresting?Rudy Juliano
Molecules and Cells|June 5, 2004
Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathwaysJung Weon Lee, Rudy Juliano
Journal of Drug Targeting|April 7, 2010
The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotidesLeaf Huang, Bruce Sullenger, Rudy Juliano
Advanced Drug Delivery Reviews|September 4, 2012
Perspective from the founding editors. PrefaceRudy Juliano, George Poste, Eric Tomlinson
Bioconjugate Chemistry|December 21, 2013
Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotidesOsamu Nakagawa, Xin Ming, Kyle Carver, et al.
Nucleic Acids Research|June 19, 2008
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesRudy Juliano, Md Rowshon Alam, Vidula Dixit, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Cell Biology|May 1, 2009
SCAI blocks MAL-evolent effects on cancer cell invasionRudy Juliano
Nature Cell Biology|July 2, 2003
Movin' on through with Cdc2Rudy Juliano
Science (New York, N.Y.)|April 27, 2013
Strategy behind science policy decisionsRudy Juliano
The New England Journal of Medicine|March 3, 2007
Bugging tumors to put drugs on targetRudy Juliano
Nature Reviews. Drug Discovery|March 2, 2013
Nanomedicine: is the wave cresting?Rudy Juliano
Molecules and Cells|June 5, 2004
Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathwaysJung Weon Lee, Rudy Juliano
Journal of Drug Targeting|April 7, 2010
The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotidesLeaf Huang, Bruce Sullenger, Rudy Juliano
Advanced Drug Delivery Reviews|September 4, 2012
Perspective from the founding editors. PrefaceRudy Juliano, George Poste, Eric Tomlinson
Bioconjugate Chemistry|December 21, 2013
Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotidesOsamu Nakagawa, Xin Ming, Kyle Carver, et al.
Nucleic Acids Research|June 19, 2008
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesRudy Juliano, Md Rowshon Alam, Vidula Dixit, et al.
Pageof 2